Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS study
about
Lymphocytes as Biomarkers of Therapeutic Response in Rheumatic Autoimmune Diseases, Is It a Realistic Goal?Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects.Stratifying primary Sjögren's syndrome: killers in the balance?BAFF- and APRIL-targeted therapy in systemic autoimmune diseases.Sjögren syndromeIFI16 filament formation in salivary epithelial cells shapes the anti-IFI16 immune response in Sjögren's syndrome
P2860
Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS study
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Low numbers of blood and saliv ...... e: results of the BELISS study
@ast
Low numbers of blood and saliv ...... e: results of the BELISS study
@en
type
label
Low numbers of blood and saliv ...... e: results of the BELISS study
@ast
Low numbers of blood and saliv ...... e: results of the BELISS study
@en
prefLabel
Low numbers of blood and saliv ...... e: results of the BELISS study
@ast
Low numbers of blood and saliv ...... e: results of the BELISS study
@en
P2093
P2860
P50
P1476
Low numbers of blood and saliv ...... e: results of the BELISS study
@en
P2093
Frédéric Desmoulins
Gaétane Nocturne
Houria Hendel-Chavez
Mohcine Benbijja
Rakiba Belkhir
Raphaèle Seror
Thierry Lazure
Xavier Mariette
Yacine Taoufik
P2860
P2888
P356
10.1186/S13075-015-0750-Y
P577
2015-09-04T00:00:00Z